Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02489903
Title RRx-001 in Small, Non-small Cell Lung Cancer, and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors EpicentRx, Inc.
Indications

lung small cell carcinoma

lung non-small cell carcinoma

neuroendocrine tumor

Therapies

Etoposide

RRx-001

Carboplatin

Cisplatin

Nab-paclitaxel

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University Palo Alto California 94304 United States Details
VA Connecticut Cancer Center West Haven Connecticut 06516 United States Details
Memorial Hospital of South Bend South Bend Indiana 46601 United States Details
Baptist Health Lexington Kentucky 40503 United States Details
Walter Reed National Military Medical Center Bethesda Maryland 20889 United States Details
Henry Ford Allegiance Health Jackson Michigan 49201 United States Details
Washington University Saint Louis Missouri 63110 United States Details
University of Cincinnati Cancer Institute Cincinnati Ohio 45267 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
West Virginia University Morgantown West Virginia 26506 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field